CytoDyn Inc. (CYDY)
CYDY Stock Price Chart
Explore CytoDyn Inc. interactive price chart. Choose custom timeframes to analyze CYDY price movements and trends.
CYDY Company Profile
Discover essential business fundamentals and corporate details for CytoDyn Inc. (CYDY) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
13 Dec 2006
Employees
9.00
Website
https://www.cytodyn.comCEO
Jacob P. Lalezari
Description
CytoDyn Inc. operates as a clinical-stage biotechnology company. The company focuses on developing treatments for multiple therapeutic indications based on leronlimab, a novel humanized monoclonal antibody targeting the CCR5 receptor in the areas of human immunodeficiency virus (HIV), non-alcoholic steatohepatitis (NASH), oncology, and such as coronavirus disease (COVID-19). It is also conducting a Phase 1b/2 clinical trial with leronlimab in metastatic triple-negative breast cancer. The company was formerly known as RexRay Corporation. CytoDyn Inc. was incorporated in 2002 and is based in Vancouver, Washington.
CYDY Financial Timeline
Browse a chronological timeline of CytoDyn Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 13 Apr 2026
Upcoming earnings on 12 Jan 2026
Upcoming earnings on 15 Oct 2025
Earnings released on 25 Jul 2025
EPS came in at -$0.01 .
Earnings released on 14 Apr 2025
EPS came in at -$0.00 .
Earnings released on 14 Jan 2025
EPS came in at -$0.00 .
Earnings released on 15 Oct 2024
EPS came in at $0.02 .
Earnings released on 15 Aug 2024
EPS came in at -$0.02 , while revenue for the quarter reached $50.00K .
Earnings released on 15 Apr 2024
EPS came in at -$0.01 .
Earnings released on 16 Jan 2024
EPS came in at -$0.01 .
Earnings released on 13 Sept 2023
EPS came in at -$0.02 .
Earnings released on 21 Aug 2023
EPS came in at -$0.02 .
Earnings released on 10 Apr 2023
EPS came in at -$0.02 .
Earnings released on 9 Jan 2023
EPS came in at -$0.03 .
Earnings released on 11 Oct 2022
EPS came in at -$0.03 .
Earnings released on 15 Aug 2022
EPS came in at -$0.15 falling short of the estimated -$0.04 by -284.77%, while revenue for the quarter reached $41.00K .
Earnings released on 11 Apr 2022
EPS came in at -$0.05 falling short of the estimated -$0.04 by -25.00%.
Earnings released on 10 Jan 2022
EPS came in at -$0.06 falling short of the estimated -$0.04 by -43.45%, while revenue for the quarter reached $225.00K .
Earnings released on 12 Oct 2021
EPS came in at -$0.05 matching the estimated -$0.05, while revenue for the quarter reached $41.00K .
Earnings released on 30 Jul 2021
EPS came in at -$0.08 falling short of the estimated -$0.05 by -60.00%.
Earnings released on 14 Apr 2021
EPS came in at -$0.06 falling short of the estimated -$0.05 by -20.00%.
Earnings released on 8 Jan 2021
EPS came in at -$0.06 falling short of the estimated -$0.05 by -20.00%.
Earnings released on 9 Oct 2020
EPS came in at -$0.06 matching the estimated -$0.06.
CYDY Stock Performance
Access detailed CYDY performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.